Short-Term Insomnia
Short-term insomnia is a sleep disorder characterized by difficulty falling asleep or staying asleep for a brief period, often lasting a few days to a few weeks, usually triggered by stress or changes in routine.
Short-Term Insomnia: Neurexan® Treatment
We are exploring whether Neurexan® can improve sleep quality and daytime performance in people with short-term insomnia. This study compares its effects to a placebo to understand its potential benefits.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 65 years old?
- Have you had insomnia symptoms for less than 3 months?
- Are you currently pregnant or breastfeeding?
- Is your Body Mass Index (BMI) between 18.5 and 29.9?
- Are you taking any medications that affect sleep, like antidepressants or blood pressure drugs?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Dormi Gastreu R14
Dr. Reckeweg R14 Quieta
Dr. Reckeweg R14 Valeriana-Gastreu
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Jena KöR
Department of Psychiatry and Psychotherapy
Jena, Germany
Sponsor: Biologische Heilmittel Heel GmbH
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.